Jim Belinda, Mehta Swati, Qipo Andi, Kim Kwanghee, Cohen Hillel W, Moore Robert M, He John C, Sharma Shuchita
Jacobi Medical Center, Albert Einstein College of Medicine, Department of Nephrology/Medicine, Bronx, New York, United States of America.
James J. Peters VA Medical Center, Department of Nephrology/Medicine, Bronx, New York, United States of America.
PLoS One. 2014 Jul 10;9(7):e101445. doi: 10.1371/journal.pone.0101445. eCollection 2014.
Preeclampsia, a hypertensive multisystem disease that complicates 5-8% of all pregnancy, is a major cause for maternal and fetal mortality and morbidity. The disease is associated with increased spontaneous and evoked preterm birth and remote cardio-renal disorders in the mother and offspring. Thus the ability to predict the disease should lead to earlier care and decreased morbidity. This has led to fervent attempts to identify early predictive biomarkers and research endeavors that have expanded as we learn more regarding possible causes of the disease. As preeclampsia is associated with specific renal pathology including podocyte injury, early urinary podocyte (podocyturia), or the podocyte specific proteinuria nephrin in the urine (nephrinuria), as well as the more easily measured urinary albumin (albuminuria), have all been suggested as predictive markers. We performed a prospective study recruiting 91 pregnant women (78 of whom were high risk) and studied the predictive ability of these three urinary biomarkers. The subjects were recruited between 15-38 weeks of gestation. Fourteen patients, all in the high-risk obstetric group, developed preeclampsia. The levels of podocyturia, nephrinuria, and albuminuria were variably higher in the high-risk pregnant patients who developed preeclampsia. The sensitivities and specificities for podocyturia were 70% and 43%, for albuminuria were 36% and 96%, and for nephrinuria were 57% and 58%, respectively. Also, abnormal nephrinuria (69%) and podocyturia (38%) were detected in low risk women who had uncomplicated gestations; none of these women exhibited albuminuria. In our study, none of the three urinary markers achieved the minimum predictive values required for clinical testing. The lack of excessive albuminuria, however, may indicate a preeclampsia-free gestation. Given a discrepant literature, further studies with larger sample size should be considered.
子痫前期是一种使5%-8%的妊娠复杂化的高血压多系统疾病,是孕产妇和胎儿死亡及发病的主要原因。该疾病与母亲和后代的自然早产和诱发早产增加以及远期心肺肾疾病有关。因此,预测该疾病的能力应能带来更早的护理并降低发病率。这促使人们热切地试图识别早期预测生物标志物,并且随着我们对该疾病可能病因的了解增多,相关研究工作也在不断扩展。由于子痫前期与包括足细胞损伤在内的特定肾脏病理相关,早期尿足细胞(足细胞尿)、尿液中足细胞特异性蛋白尿nephrin(nephrin尿)以及更易检测的尿白蛋白(白蛋白尿)都被认为是预测标志物。我们进行了一项前瞻性研究,招募了91名孕妇(其中78名是高危孕妇),并研究了这三种尿液生物标志物的预测能力。研究对象在妊娠15-38周期间招募。14名患者,均来自高危产科组,发生了子痫前期。发生子痫前期的高危孕妇中,足细胞尿、nephrin尿和白蛋白尿水平不同程度升高。足细胞尿的敏感性和特异性分别为70%和43%,白蛋白尿为36%和96%,nephrin尿为57%和58%。此外,在妊娠未出现并发症的低风险女性中检测到异常nephrin尿(69%)和足细胞尿(38%);这些女性均未出现白蛋白尿。在我们的研究中,这三种尿液标志物均未达到临床检测所需的最低预测值。然而,缺乏过量白蛋白尿可能表明妊娠未发生子痫前期。鉴于文献结果存在差异,应考虑进行更大样本量的进一步研究。